| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.0M | -15.9% |
| SG&A Expense | $27.3M | -63.6% |
| Operating Income | -$44.3M | +61.7% |
| Interest Expense | $18K | +0.0% |
| Pre-tax Income | -$39.8M | +57.3% |
| Net Income | -$39.8M | +57.3% |
| EPS (Basic) | -$0.60 | +69.7% |
| EPS (Diluted) | -$0.60 | +69.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.1M | -27.4% |
| Accounts Receivable | $7K | — |
| Current Assets | $25.8M | -21.1% |
| Total Assets | $25.8M | -21.1% |
| Current Liabilities | $15.6M | +30.7% |
| Total Liabilities | $18.4M | +54.4% |
| Stockholders' Equity | $7.4M | -64.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.8M | -5.4% |
| Investing Cash Flow | -$10K | -42.9% |
| Financing Cash Flow | $32.2M | -49.2% |